Question 1

What is the catalog number for LyP-1 TFA?

Accepted Answer

The catalog number for LyP-1 TFA is orb2278936.

Question 2

What sizes are available for LyP-1 TFA?

Accepted Answer

LyP-1 TFA is available in the following size(s): 5 mg, 50 mg.

Question 3

How many pack sizes does LyP-1 TFA come in?

Accepted Answer

LyP-1 TFA is available in 2 different pack sizes.

Question 4

Is LyP-1 TFA in stock?

Accepted Answer

LyP-1 TFA is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is LyP-1 TFA used for?

Accepted Answer

LyP-1 TFA is a cyclic nonapeptide that selectively targets the p32 receptor, a protein overexpressed on many tumor and tumor-associated cells. It is a valuable research tool for studying targeted drug delivery and tumor biology in both in vitro and in vivo models.

Question 6

What is the sensitivity of this ELISA kit?

Accepted Answer

Assay sensitivity, including the minimum detectable dose, is listed on the datasheet. Kits that are assembled on order typically ship within 2-4 weeks.

Question 7

Do you ship this product with dry ice?

Accepted Answer

Some products, including certain cell lines and biologics, require dry ice for transportation, which carries an additional fee shown clearly in your quotation. Dry ice delivery isn’t always possible to every destination due to transit time or local restrictions, so we check feasibility in advance and you must store the goods at the correct temperature the moment they arrive.

Question 8

Is this product species cross-reactive?

Accepted Answer

Cross-reactivity data, based on available testing, is listed under the reactivity section of the datasheet. Contact us if you need reactivity confirmed for a species not listed.

LyP-1 TFA

Product Specifications

Field of Research

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

KDR siRNA (Human)

KDR siRNA (Human)

Ensartinib (dihydrochloride)

Ensartinib (dihydrochloride)

Ensartinib (dihydrochloride)

Ensartinib (dihydrochloride)